Progyny, Inc. Common Stock
PGNY
PGNY: Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.
moreShow PGNY Financials
Recent trades of PGNY by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by PGNY's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Apparatus, method, and system for image-based human embryo cell classification Jul. 18, 2017
-
Patent Title: Apparatus, method, and system for automated, non-invasive cell activity tracking Jan. 10, 2017
-
Patent Title: Apparatus, method, and system for the automated imaging and evaluation of embryos, oocytes and stem cells Nov. 01, 2016
-
Patent Title: Apparatus, method, and system for image-based human embryo cell classification Nov. 03, 2015
Federal grants, loans, and purchases
Followers on PGNY's company Twitter account
Number of mentions of PGNY in WallStreetBets Daily Discussion
Recent insights relating to PGNY
Recent picks made for PGNY stock on CNBC
ETFs with the largest estimated holdings in PGNY
Flights by private jets registered to PGNY